Hi-Tech Pharmacal Co. (HITK) Misses Q4 EPS by 8c; Revs Light
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Income tax expense: 3.96M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Income tax expense: 3.96M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q4 EPS of $0.79, $0.08 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $55.63 million versus the consensus estimate of $55.73 million.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Northeast Community Bancorp, Inc. (NECB) Tops Q1 EPS by 12c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
